In November 2017, Asana Medical, Inc. announced that they had formally changed their name to Regentys, as a more distinctive representation of their business model and underlying regenerative medicine technology.

Asana Medical’s Treatment of IBD Progresses with Execution of Research Agreement with University of Pittsburgh

Sept. 9, 2015

Asana has executed a Corporate Research Agreement (“CRA”) with the University of Pittsburgh to develop products based on intellectual property recently licensed from the University.

Read More →

Asana Medical, Inc. Secures Core Technology License for Treatment of IBD Including Ulcerative Colitis

June 3, 2015

Asana has obtained a world-wide, field specific, exclusive license from the University of Pittsburgh on multiple patents and patent applications covering methods and for treating Inflammatory Bowel Disease without a colectomy, including the use of Extracellular Matrix-derived gels and their methods for preparation and sterilization.

Read More →

Asana Medical, Inc. to Present at 2015 BIO International Convention June 15th – 18th

June 1, 2015

Asana will be participating as an exhibitor and presenter at the 2015 BIO International Convention being held in Philadelphia, PA. June 15th – 18th

Read More →

Asana Medical Video

May 5, 2015

Rich Newberg, Senior Correspondent for WIVB News 4 Buffalo visits with Asana CEO Marc Ramer at 43North’s incubator.

Read More →

Asana Medical, Inc. to Exhibit at Gold Coast Venture Capital Association 2015 Expo on February 24th

Feb. 12, 2015

Asana will be exhibiting at the Gold Coast Venture Capital Association (“GCVCA”) 2015 Expo in Boca Raton, Florida on February 24th. Chief Executive Officer Marc Ramer will represent Asana Medical at the Expo.

Read More →